EDAP TMS S.A. (EDAP) Reports Q1 Loss of EUR0.10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Broadcom secures role as key Apple supplier with chip deal through 2031
- Dara Khosrowshahi steps down from Grab Holdings board
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- HSBC Downgrades Shriram Finance Ltd (SHFL:IN) to Hold
- Lockheed Martin to acquire Ultra Maritime for $3.45 billion
EDAP Reports First Quarter 2015 Results
May 12, 2015 4:05 PM EDT1Q 2015 and Recent Operational Highlights
Direct De Novo petition for Ablatherm HIFU submitted to the FDA in April 2015; Treatment-driven revenue from the HIFU division increased 17% year-over-year; Revenue for first quarter 2015 totaled EUR 6.2 million (USD 6.9 million); Canadian regulatory approval of Focal One; first device sold and initial patients successfully treated Cash position remains strong at EUR 11.3 million (USD 12.1 million) as of March 31, 2015;LYON, France, May 12, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced financial results for the first... More

